This research aims to understand the multifaceted pathomechanisms linked to ANKRD26-RET and their role in cell proliferation.
Examined intrinsic pathomechanisms involved in ANKRD26-RET interactions.
Focused on aberrant RET kinase activity and ANKRD26 dysfunctions.
Proposed potential therapeutic interventions targeting these mechanisms.
Identified that RET kinase activity alone does not explain all proliferation effects.
Highlighted the importance of targeting ANKRD26 dysfunctions for effective treatment.
Proposed new strategies for cancer interventions that focus on combined pathomechanisms.
Abstract
-intrinsic pathomechanisms may not be solely brought about by aberrant RET kinase activity but that putative therapeutic interventions may additionally need to focus on ANKRD26 dysfunctions.